Alveole Presents Its New PRIMO Photopatterning Technology At American Society for Cell Biology 2016
Alvéole is presenting its new PRIMO® multi-protein photopatterning solution at the annual congress of the American Society for Cell Biology (ASCB). Technical presentations on the technology and its applications will be organized from December 4 thru 6 on Alvéole’s exhibition booth, No 1017.
PRIMO has been created to enable biologists to design and carry out all the micropatterning experiments that they can think of, on 2D and also in 3D. With this tool, it is now possible to accurately and easily adjust protein micropatterns made of proteins and so to easily control the cellular microenvironment, whether to study the effect of a molecule or to imitate the physiological conditions. PRIMO offers new possibilities for multiple applications, such as research on stem cells, cell tests for developing drugs and predictive toxicology to respond to the major public health challenges in oncology, immunology or neurology.
The PRIMO® multi-protein photopatterning technique is based on LIMAP technology (Light Induced Molecular Adsorption of Proteins) and combines a UV illumination system controlled by a dedicated software (Leonardo) with a specific light-activated reagent (PLPP). The combined action of these two components makes it possible, in a few seconds, to generate any pattern with several proteins on standard cell culture substrates, at micrometer scale and with excellent reproducibility.
About Alvéole
Alvéole develops innovative tools to control the cellular microenvironment, so enabling biologists to control the development and proliferation of living cells in culture.
The company was founded in 2010 by three researchers from the French National Center for Scientific Research (CNRS)(3),(4),(5) collaborating with Quattrocento, a ‘creator of companies’ in the life sciences field making it possible for academic researchers to convert their inventions into marketed products.
In June 2016, after 6 years of industrial development, Alvéole launched its first product, PRIMO, which won the New Product Award at the SLAS annual congress (Society for Laboratory Automation and Screening) at San Diego in January 2016.
PRIMO has been created to enable biologists to design and carry out all the micropatterning experiments that they can think of, on 2D and also in 3D. With this tool, it is now possible to accurately and easily adjust protein micropatterns made of proteins and so to easily control the cellular microenvironment, whether to study the effect of a molecule or to imitate the physiological conditions. PRIMO offers new possibilities for multiple applications, such as research on stem cells, cell tests for developing drugs and predictive toxicology to respond to the major public health challenges in oncology, immunology or neurology.
The PRIMO® multi-protein photopatterning technique is based on LIMAP technology (Light Induced Molecular Adsorption of Proteins) and combines a UV illumination system controlled by a dedicated software (Leonardo) with a specific light-activated reagent (PLPP). The combined action of these two components makes it possible, in a few seconds, to generate any pattern with several proteins on standard cell culture substrates, at micrometer scale and with excellent reproducibility.
About Alvéole
Alvéole develops innovative tools to control the cellular microenvironment, so enabling biologists to control the development and proliferation of living cells in culture.
The company was founded in 2010 by three researchers from the French National Center for Scientific Research (CNRS)(3),(4),(5) collaborating with Quattrocento, a ‘creator of companies’ in the life sciences field making it possible for academic researchers to convert their inventions into marketed products.
In June 2016, after 6 years of industrial development, Alvéole launched its first product, PRIMO, which won the New Product Award at the SLAS annual congress (Society for Laboratory Automation and Screening) at San Diego in January 2016.